Aleksandra Fucic

Independent Researcher: Aleksandra Fučić, genotoxicologist

PhD / Permanent Scientific Advisor / Head of Unit

Curriculum vitae

Aleksandra Fucic has 30 years of research experience in genotoxicology and biomonitoring. She is a Scientific Adviser at the Institute for Medical Research and Occupational Health, Zagreb. Her main scientific interests are carcinogenesis mechanisms after exposure to chemical and physical agents including transplacental exposure and life long health risks. She has published over 100 papers and several books. She is a Fellow of Collegium Ramazzini. Dr Fučić took part in many international and national projects, European biomonitoring programs and reports. Currently she is a partner in the largest European biomonitoring project HBM4EU in which she is focused on investigation of occupational and environmental endocrine disruptor exposures.

Place and date of birth

Zagreb, 6 June 1959


  • Faculty of Science, Zagreb, Croatia

Fields of interest

genotoxicology, cancerogenesis, systems biology

Select Publications

  1. Fucic A, Maric T, Vicic Bockor V, Jezek D. In vivo acridine orange human spermatozoa staining-A new perspective for RNA detection and spermatozoa morphology evaluation. Anat Histol Embryol. 2021 Jan;50(1):102-107.
  2. Fréry N, Santonen T, Porras SP, Fucic A, Leso V, Bousoumah R, Duca RC, El Yamani M, Kolossa-Gehring M, Ndaw S, Viegas S, Iavicoli I. Biomonitoring of occupational exposure to phthalates: A systematic review. Int J Hyg Environ Health. 2020 Aug;229:113548.
  3. Fucic A, Druzhinin V, Aghajanyan A, Slijepcevic P, Bakanova M, Baranova E, Minina V, Golovina T, Kourdakov K, Timofeeva A, Titov V. Rogue versus chromothriptic cell as biomarker of cancer. Mutat Res. 2020 Apr-Jun;784:108299.
  4. Fucic A, Galea KS, Duca RC, El Yamani M, Frery N, Godderis L, Halldorsson TI, Iavicoli I, Ndaw S, Ribeiro E, Viegas S, Moshammer H. Potential Health Risk of Endocrine Disruptors in Construction Sector and Plastics Industry: A New Paradigm in Occupational Health. Int J Environ Res Public Health. 2018 Jun 11;15(6):1229.
  5. Fucic A, Guszak V, Mantovani A. Transplacental exposure to environmental carcinogens:Association with childhood cancer risks and the role of modulating factors. Reprod Toxicol. 2017 Sep;72:182-190.
  6. Fucic A, Guszak V, Keser T, Wagner J, Juretić E, Plavec D, Stojković R, Gornik O, Lauc G. Micronucleus, cell-free DNA, and plasma glycan composition in the newborns of healthy and diabetic mothers. Mutat Res. 2017 Mar;815:6-15.


  • European Environmental Mutagen Society
  • Collegium Ramazzini


Selected projects

  • Human Micronucleus Collaborative Study, HUMN (M. Fenech, CSIRO, Australia 1995-2002
  • Cytogenetic Biomarkers and Human Cancer Risk” (coordinator H. Norppa, Finland European Commission, FP5) 2001-2004
  • “European network on children susceptibility and exposure to environmental genotoxicants”, (coordinator : L. Knudsen, Denmark, European Commission, FP5), 2002-2005
  • Policy interpretation network on children’s health and environment (coordinator P.van den Hazel, Netherlands, European Commission, FP5), 2002-2005
  • Health and Environment Network (coordinator: A. Bartonova, Norway European Commission, FP6) 2006-2010
  • Newborns and genotoxic risks: Development and application of biomarkers of dietary exposure to genotoxic and immunotoxic chemicals and of biomarkers of early effects, using mother-child birth cohorts and biobanks, (coordinator J. Kleinjans, Netherlands, European Commission, FP6) 2005-2011
  • Expert team to support biomonitoring in Europe (coordinator R. Joas, Germany, European Commission, FP6) 2006-2009
  • European Coordination action on human biomonitoring (coordinator R. Joas, Germany, European Commission, FP 7) 2009-2012
  • Demonstration of a study to coordinate and perform human biomonitoring on a European scale,( LIFE09 ENV) 2010-2012
  • Scientific Center of Excellence for Reproductive and Regenerative Medicine (CERRM); European Regional Development Fund, Operational Programme Competitiveness and Cohesion, under grant agreement No. KK., Reproductive and Regenerative Medicine – Exploring New Platforms and Potentials 2012-2022